More about Spontaneous Reports of Suspected Adverse Drug Reactions

Abstract

Get full access to this article

View all access options for this article.

References

O'Brien JD & Burnham WR Bleeding from peptic ulcers and use of non-steroidal anti-inflammatory drugs in the Romford area. British Medical Journal 1985; 291: 1609-10.

Somerville K. , Faulkner G. & Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986; i: 462-4.

Jick H. , Feld AD & Perera DR Certain non-steroidal anti-inflammatory drugs and hospitalisation for upper gastrointestinal bleeding. Pharmacotherapy 1985; 5: 280-4.

Griffin JP Survey of the spontaneous adverse drug reaction reporting schemes in 15 countries . British Journal of Clinical Pharmacology 1986; 22: 83S-100S.

Witts LJ Adverse reactions to drugs. British Medical Journal 1965; 2: 1081-6.

Doll R.

Unwanted effects of drugs. British Medical

Bulletin 1971; 27: 25-31.

Inman Whw. Postmarketing surveillance in the general population: The United Kingdom. In Monitoring for Drug Safety, ed. WHW Inman. Lancaster, MTP Press , 1980.

Idanpaan-Heikkila J. , Alhava F. , Olkinuora M. & Palva IP Agranulocytosis during treatment with clozapine . European Journal of Clinical Pharmacology 1977; 10: 1-5.

Committee on Safety of Medicines. Zimeldine. Current Problems, No. 11. 1982.

10.

Committee on Safety of Medicines Update. Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions (1). British Medical Journal 1986; 292: 614.

11.

Committee on Safety of Medicines Update. Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions (2). British Medical Journal 1986; 292: 1190-1.

12.

Fok KH , George Pjm & Vicary FR Peptic ulcers induced by piroxicam. British Medical Journal 1985; 290: 117-8.

13.

Rossi AC , Hsu JP & Faich GA Ulcerogenicity of piroxicam: an analysis of spontaneously reported data. British Medical Journal 1987; 294: 147-50.

14.

Sachs RM & Bortnichak EA An evaluation of spontaneous adverse drug reactions monitoring systems. American Journal of Medicine 1986; 81 (suppl. 5B): 49-55.

15.

Bortnichak EA & Sachs RM Piroxicam in recent epidemiologic studies . American Journal of Medicine 1986; 81 (suppl. 5B); 44-8.

16.

Meisel AD Clinical benefits and comparative safety of piroxicam: analysis of world-wide clinical trials data. American Journal of Medicine 1986; 81 (suppl. 5B) 15-21.

17.

Dollery CT & Rawlins MD Monitoring adverse reactions to new drugs. British Medical Journal 1977; 1: 96-7.

18.

Lawson DH & Henry DA

Monitoring adverse reactions to new drugs: restricted release or monitored release?

British Medical Journal 1977; 1: 691-2.

19.

Grahame-Smith DG Report of the Adverse Reaction Working Party to the Committee on Safety of Medicines. London: Department of Health & Social Security, 1986.

20.

CIOMS Working Group Report. Monitoring and Assessment of Adverse Drug Effects. Geneva : Council for International Organisations of Medical Sciences, 1986.

21.

Rawlins MD Spontaneous reporting of adverse drug reactions. Quarterly Journal of Medicine 1986; 230: 531-4.

22.

Spiers CJ , Griffin JP , Weber Jcp , Glen-Bott M & Twomey C. Demography of the UK Adverse Reactions Register . Health Trends 1984; 16: 49-52.